CRH PLC (CRH)

IE0001827041 - Common Stock

77.2  -0.43 (-0.55%)

Premarket: 77.96 +0.76 (+0.98%)

Fundamental Rating

5

CRH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 12 industry peers in the Construction Materials industry. While CRH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CRH has a bad growth rate and is valued cheaply. With these ratings, CRH could be worth investigating further for value investing!.



7

1. Profitability

1.1 Basic Checks

CRH had positive earnings in the past year.
CRH had a positive operating cash flow in the past year.
Each year in the past 5 years CRH has been profitable.
In the past 5 years CRH always reported a positive cash flow from operatings.

1.2 Ratios

CRH has a better Return On Assets (9.16%) than 75.00% of its industry peers.
CRH has a better Return On Equity (20.84%) than 83.33% of its industry peers.
CRH's Return On Invested Capital of 12.61% is fine compared to the rest of the industry. CRH outperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRH is below the industry average of 10.43%.
The 3 year average ROIC (8.13%) for CRH is below the current ROIC(12.61%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.16%
ROE 20.84%
ROIC 12.61%
ROA(3y)7.04%
ROA(5y)5.45%
ROE(3y)15.35%
ROE(5y)12.15%
ROIC(3y)8.13%
ROIC(5y)7.16%

1.3 Margins

CRH has a Profit Margin of 8.51%. This is comparable to the rest of the industry: CRH outperforms 41.67% of its industry peers.
In the last couple of years the Profit Margin of CRH has declined.
CRH has a Operating Margin (11.97%) which is comparable to the rest of the industry.
CRH's Operating Margin has improved in the last couple of years.
CRH has a better Gross Margin (33.76%) than 83.33% of its industry peers.
CRH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.97%
PM (TTM) 8.51%
GM 33.76%
OM growth 3Y6.45%
OM growth 5Y7.01%
PM growth 3Y30.76%
PM growth 5Y-2.84%
GM growth 3Y0.1%
GM growth 5Y0.64%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRH is creating value.
Compared to 1 year ago, CRH has less shares outstanding
Compared to 5 years ago, CRH has less shares outstanding
CRH has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 3.59 indicates that CRH is not in any danger for bankruptcy at the moment.
CRH has a Altman-Z score (3.59) which is comparable to the rest of the industry.
The Debt to FCF ratio of CRH is 3.67, which is a good value as it means it would take CRH, 3.67 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CRH (3.67) is comparable to the rest of the industry.
CRH has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
CRH has a better Debt to Equity ratio (0.48) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.67
Altman-Z 3.59
ROIC/WACC1.92
WACC6.58%

2.3 Liquidity

CRH has a Current Ratio of 1.69. This is a normal value and indicates that CRH is financially healthy and should not expect problems in meeting its short term obligations.
CRH's Current ratio of 1.69 is on the low side compared to the rest of the industry. CRH is outperformed by 66.67% of its industry peers.
A Quick Ratio of 1.26 indicates that CRH should not have too much problems paying its short term obligations.
CRH has a Quick ratio (1.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.26

3

3. Growth

3.1 Past

The earnings per share for CRH have decreased strongly by -23.59% in the last year.
The Earnings Per Share has been growing slightly by 4.44% on average over the past years.
The Revenue has been growing slightly by 7.05% in the past year.
CRH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.95% yearly.
EPS 1Y (TTM)-23.59%
EPS 3Y45.38%
EPS 5Y4.44%
EPS growth Q2Q-13.7%
Revenue 1Y (TTM)7.05%
Revenue growth 3Y8.2%
Revenue growth 5Y4.95%
Revenue growth Q2Q6.8%

3.2 Future

The Earnings Per Share is expected to grow by 0.96% on average over the next years.
Based on estimates for the next years, CRH will show a small growth in Revenue. The Revenue will grow by 3.94% on average per year.
EPS Next Y20.01%
EPS Next 2Y13.9%
EPS Next 3Y11.98%
EPS Next 5Y0.96%
Revenue Next Year4.66%
Revenue Next 2Y4.7%
Revenue Next 3Y4.55%
Revenue Next 5Y3.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

CRH is valuated correctly with a Price/Earnings ratio of 12.70.
Based on the Price/Earnings ratio, CRH is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
CRH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.20.
A Price/Forward Earnings ratio of 14.20 indicates a correct valuation of CRH.
91.67% of the companies in the same industry are more expensive than CRH, based on the Price/Forward Earnings ratio.
CRH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.7
Fwd PE 14.2

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRH is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CRH is valued cheaper than 91.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.17
EV/EBITDA 7.78

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRH may justify a higher PE ratio.
PEG (NY)0.63
PEG (5Y)2.86
EPS Next 2Y13.9%
EPS Next 3Y11.98%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.78%, CRH has a reasonable but not impressive dividend return.
CRH's Dividend Yield is a higher than the industry average which is at 2.59.
Compared to the average S&P500 Dividend Yield of 2.44, CRH is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.78%

5.2 History

The dividend of CRH decreases each year by -36.34%.
CRH has paid a dividend for at least 10 years, which is a reliable track record.
CRH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-36.34%
Div Incr Years4
Div Non Decr Years4

5.3 Sustainability

CRH pays out 21.63% of its income as dividend. This is a sustainable payout ratio.
DP21.63%
EPS Next 2Y13.9%
EPS Next 3Y11.98%

CRH PLC

NYSE:CRH (4/25/2024, 7:04:00 PM)

Premarket: 77.96 +0.76 (+0.98%)

77.2

-0.43 (-0.55%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap54.94B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.78%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 12.7
Fwd PE 14.2
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.63
PEG (5Y)2.86
Profitability
Industry RankSector Rank
ROA 9.16%
ROE 20.84%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.97%
PM (TTM) 8.51%
GM 33.76%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.69
Quick Ratio 1.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-23.59%
EPS 3Y45.38%
EPS 5Y
EPS growth Q2Q
EPS Next Y20.01%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.05%
Revenue growth 3Y8.2%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y